Matarin Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-927,289
| Closed | -$2.17M | – | 328 |
|
|
2018
Q2 | $2.17M | Sell |
927,289
-199,352
| -18% | -$466K | 0.16% | 164 |
|
|
2018
Q1 | $3.31M | Buy |
1,126,641
+88,469
| +9% | +$260K | 0.25% | 143 |
|
|
2017
Q4 | $2.84M | Buy |
1,038,172
+996,002
| +2,362% | +$2.73M | 0.22% | 150 |
|
|
2017
Q3 | $143K | Buy |
+42,170
| New | +$143K | 0.01% | 285 |
|
|
2014
Q1 | – | Sell |
-15,753
| Closed | -$133K | – | 184 |
|
|
2013
Q4 | $133K | Buy |
+15,753
| New | +$133K | 0.08% | 120 |
|